Showing 1 - 5 results of 5 for search 'Jennifer H Yearley', query time: 0.03s Refine Results
  1. 1
    Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study

    Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study by Qing Zhao, Jeeyun Lee, Razvan Cristescu, Xiao Qiao Liu, Jennifer H. Yearley, Seung Tae Kim, Yuan Sun, Irene M. Shui, Tasmiah Choudhury, Andrea L. Webber, Clemens Krepler

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).

    Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE). by Prasanna M Chandramouleeswaran, Dawen Shen, Anna J Lee, Alain Benitez, Kara Dods, Fiona Gambanga, Benjamin J Wilkins, Jamie Merves, Yuliana Noah, Sarit Toltzis, Jennifer H Yearley, Jonathan M Spergel, Hiroshi Nakagawa, Rene deWaal Malefyt, Amanda B Muir, Mei-Lun Wang

    Published 2016-01-01
    Get full text
    Article
  3. 3
    High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease

    High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease by Sjoerd P. F. T. Nota, Sjoerd P. F. T. Nota, Ahmad Al-Sukaini, Ahmad Al-Sukaini, Shalin S. Patel, Shalin S. Patel, Francesco Sabbatino, G. Petur Nielsen, G. Petur Nielsen, Vikram Deshpande, Vikram Deshpande, Jennifer H. Yearley, Soldano Ferrone, Soldano Ferrone, Xinhui Wang, Joseph H. Schwab, Joseph H. Schwab

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection

    Antibody-drug conjugates: integrated bioanalytical and biodisposition assessments in lead optimization and selection by Maribel Beaumont, Daniela Tomazela, Douglas Hodges, Grigori Ermakov, Edward Hsieh, Isabel Figueroa, On-Yee So, Yaoli Song, Huiping Ma, Svetlana Antonenko, Wondwessen Mengesha, Yi Wei Zhang, Shuli Zhang, SuChun Hseih, Gulesi Ayanoglu, Xiaoyan Du, Eric Rimmer, Michael Judo, Franklin Vives, Jennifer H. Yearley, Christina Moon, Anthony Manibusan, Nick Knudsen, Andy Beck, Damien Bresson, Dennis Gately, Divas Neupane, Enrique Escandón

    Published 2018-08-01
    Get full text
    Article
  5. 5
    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab by Nicolas A. Giraldo, Peter Nguyen, Elizabeth L. Engle, Genevieve J. Kaunitz, Tricia R. Cottrell, Sneha Berry, Benjamin Green, Abha Soni, Jonathan D. Cuda, Julie E. Stein, Joel C. Sunshine, Farah Succaria, Haiying Xu, Aleksandra Ogurtsova, Ludmila Danilova, Candice D. Church, Natalie J. Miller, Steve Fling, Lisa Lundgren, Nirasha Ramchurren, Jennifer H. Yearley, Evan J. Lipson, Mac Cheever, Robert A. Anders, Paul T. Nghiem, Suzanne L. Topalian, Janis M. Taube

    Published 2018-10-01
    Get full text
    Article

Search Tools: